Ventas Outpatient medical and research portfolio (OM&R) — Goodwill remained flat by 0.0% to $466.97M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Stable or decreasing levels are generally preferred; significant increases suggest recent M&A activity, while sudden decreases indicate impairment charges.
The intangible asset value representing the premium paid for acquisitions within the outpatient medical and research seg...
Common in consolidated REIT portfolios that have grown through significant corporate or portfolio acquisitions.
vtr_segment_outpatient_medical_and_research_portfolio_om_r_goodwill| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $463.80M | $466.97M | $466.97M |
| QoQ Change | — | +0.7% | +0.0% |
| YoY Change | — | +0.7% | +0.0% |